FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
Malcy Tarin(Université Paris Sciences et Lettres), Samar Alsafadi(Université Paris Sciences et Lettres)
Cited by 15
Related Papers
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
|Nature Communications|2016|383